However, a further biochemical study is required to understand the effect on cell proliferation in NSCLC by using functional siRNAs targeting a combination of TFs FOXM1, and MYBL2, and their downstream genes of “driver-network” (84). The gene discussed is MYBL2; the disease is non-small cell lung carcinoma.